Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Immunology|April 17, 2023
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responsesMatthieu Buscot, Marion Cremoni, Daisy Graça, et al.Kidney International Reports|January 16, 2023
C5b-9 Glomerular Deposits Are Associated With Poor Renal Survival in Membranous NephropathyMaxime Teisseyre, Anaïs Beyze, Hélène Perrochia, et al.Frontiers in Immunology|October 13, 2022
Low baseline IFN-γ response could predict hospitalization in COVID-19 patientsMarion Cremoni, Jonathan Allouche, Daisy Graça, et al.Kidney International Reports|February 5, 2024
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial IntelligenceAlexandre Destere, Maxime Teisseyre, Diane Merino, et al.Kidney International|October 3, 2021
Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathyMoglie Le Quintrec, Maxime Teisseyre, Nicole Bec, et al.Kidney International Reports|August 15, 2025
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous NephropathyMarco Allinovi, Maxime Teisseyre, Matteo Accinno, et al.Kidney International Reports|April 14, 2025
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab AntibodiesMaxime Teisseyre, Marco Allinovi, Vincent Audard, et al.Eclinicalmedicine|December 1, 2025
The personalized approach to rituximab treatment in membranous nephropathy: a multi-center randomized controlled trialVesna Brglez, Maxime Teisseyre, Kévin Zorzi, et al.Kidney International Reports|December 19, 2024
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney TransplantationMarion Cremoni, Maxime Teisseyre, Olivier Thaunat, et al.Pageof 2